Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
58.77%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 6.03Close
$ 2 - $ 6.8 52-Week Range
Ticker Information
Ticker
RLAYCompany Name
RELAY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRELAY THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RLAY - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 4.91M | 58.77% | $ 8.36M |
| 3/31/2025 | $ 5.28M | 68.72% | $ 7.68M |
| 12/31/2024 | $ 5.46M | 54.6% | $ 10.01M |
| 9/30/2024 | $ 5.5M | 55.02% | $ 10.01M |
| 6/30/2024 | $ 5.5M | 15.62% | $ 35.21M |
| 3/31/2024 | $ 5.47M | 15.48% | $ 35.33M |
| 12/31/2023 | $ 5.27M | 20.63% | $ 25.55M |
| 9/30/2023 | $ 5.06M | 19.61% | $ 25.8M |
| 6/30/2023 | $ 4.73M | 502.12% | $ 942K |
| 3/31/2023 | $ 4.35M | 366.33% | $ 1.19M |
Key Performance Insights, Last 5 Years
- RELAY THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 4.29%.
- Over the past 5 years, RELAY THERAPEUTICS INC's average DepAmor % has been 116.61%.
- The median DepAmor % for RELAY THERAPEUTICS INC during this period was 55.02%
- RELAY THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 502.12%.
- The lowest DepAmor % recorded by RELAY THERAPEUTICS INC in the same timeframe 4.29%
RELAY THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for RELAY THERAPEUTICS INC is calculated as follows: DepAmor [ $ 3.55M ] / Revenues [ $ 82.65M ]
(=) DepAmor % [ 4.29% ] RLAY - Depreciation and Amortization Margin, Last 5 years
4.29%
Minimum
Dec 31, 2020
502.12%
Maximum
Jun 30, 2023
116.61%
Average
55.02%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |